Recent Research | Page 76 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Oct 2013 Am J Hematol aplastic anemia
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: A treatment versus no-treatment study Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Oct 2013 Am J Hematol myelodysplastic syndromes (MDS)
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes. May 2013 Am J Hematol myelodysplastic syndromes (MDS)
Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors Jan 2015 Am J Hematol aplastic anemia
Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes Jan 2014 Am J Hematol myelodysplastic syndromes (MDS)
Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience Aug 2017 Am J Hematol aplastic anemia
Laboratory tests for paroxysmal nocturnal hemoglobinuria (PNH). Oct 2013 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes Aug 2012 Am J Hematol myelodysplastic syndromes (MDS)